MELODY registry follow-up study
Part of Genetic & congenital, Heart & circulation clinical trials.
This study is for people who have already joined the MELODY registry. It will simply continue to collect information about their condition over time to help researchers better understand how things change.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were already enrolled in the MELODY registry.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether young people with heart conditions can use a home monitoring app called Medly to track their symptoms and weight. The app may help doctors catch problems earlier and keep kids healthier at home.
This trial is a registry, meaning it collects health information to help doctors study heart muscle diseases and plan future cardiovascular studies. You may be able to join if you have a non-ischemic cardiomyopathy such as dilated cardiomyopathy, certain forms of thick heart muscle, non-compaction, or arrhythmogenic right-sided disease.
This study builds a patient registry to collect information over time about several types of cardiomyopathy (heart muscle diseases). It may help researchers understand how these conditions progress and what care works best.
This study collects information from people with congenital heart disease (a heart problem you're born with) over their entire life to better understand the condition and improve future care.
This study creates a registry of people with chronic heart failure to track their health over time. It may help researchers learn more about the condition and improve future care.
This study follows adults born with a heart condition to see how they do over time, whether they had surgery or not. It aims to learn more about their health journey.
Hear when a new Congenital Heart Disease (CHD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.